210 related articles for article (PubMed ID: 16135746)
1. Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies.
Andre J; Zeau B; Pohl M; Cesselin F; Benoliel JJ; Becker C
J Neurosci; 2005 Aug; 25(35):7896-904. PubMed ID: 16135746
[TBL] [Abstract][Full Text] [Related]
2. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia.
Rivat C; Becker C; Blugeot A; Zeau B; Mauborgne A; Pohl M; Benoliel JJ
Pain; 2010 Aug; 150(2):358-368. PubMed ID: 20573451
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat.
Becker C; Thièbot MH; Touitou Y; Hamon M; Cesselin F; Benoliel JJ
J Neurosci; 2001 Jan; 21(1):262-9. PubMed ID: 11150343
[TBL] [Abstract][Full Text] [Related]
4. Melatonin MT(1/2) receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat.
Becker C; Andre J; Zeau B; Rettori MC; Guardiola-Lemaitre B; Hamon M; Benoliel JJ
Neuropharmacology; 2004 Jun; 46(8):1158-67. PubMed ID: 15111022
[TBL] [Abstract][Full Text] [Related]
5. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin.
Becker C; Zeau B; Rivat C; Blugeot A; Hamon M; Benoliel JJ
Mol Psychiatry; 2008 Dec; 13(12):1079-92. PubMed ID: 17893702
[TBL] [Abstract][Full Text] [Related]
6. Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.
Horwell DC; Hughes J; Hunter JC; Pritchard MC; Richardson RS; Roberts E; Woodruff GN
J Med Chem; 1991 Jan; 34(1):404-14. PubMed ID: 1671419
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
Boden PR; Higginbottom M; Hill DR; Horwell DC; Hughes J; Rees DC; Roberts E; Singh L; Suman-Chauhan N; Woodruff GN
J Med Chem; 1993 Mar; 36(5):552-65. PubMed ID: 7684452
[TBL] [Abstract][Full Text] [Related]
8. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.
Benedetti F; Amanzio M; Vighetti S; Asteggiano G
J Neurosci; 2006 Nov; 26(46):12014-22. PubMed ID: 17108175
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
10. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
[TBL] [Abstract][Full Text] [Related]
11. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
Valverde O; Blommaert AG; Fournié-Zaluski MC; Roques BP; Maldonado R
Eur J Pharmacol; 1995 Nov; 286(1):79-93. PubMed ID: 8566154
[TBL] [Abstract][Full Text] [Related]
12. The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
Bickerdike MJ; Marsden CA; Dourish CT; Fletcher A
Eur J Pharmacol; 1994 Dec; 271(2-3):403-11. PubMed ID: 7705440
[TBL] [Abstract][Full Text] [Related]
13. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
[TBL] [Abstract][Full Text] [Related]
14. Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: prevention by diazepam but not ondansetron.
Nevo I; Becker C; Hamon M; Benoliel JJ
J Neurochem; 1996 May; 66(5):2041-9. PubMed ID: 8780034
[TBL] [Abstract][Full Text] [Related]
15. [Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
Izumi T
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):463-73. PubMed ID: 9846276
[TBL] [Abstract][Full Text] [Related]
16. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
Xie JY; Herman DS; Stiller CO; Gardell LR; Ossipov MH; Lai J; Porreca F; Vanderah TW
J Neurosci; 2005 Jan; 25(2):409-16. PubMed ID: 15647484
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked [3H]GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety.
Antonelli T; Tomasini MC; Mazza R; Fuxe K; Gaetani S; Cuomo V; Tanganelli S; Ferraro L
J Pharmacol Exp Ther; 2009 May; 329(2):708-17. PubMed ID: 19197005
[TBL] [Abstract][Full Text] [Related]
19. Nocebo hyperalgesia: how anxiety is turned into pain.
Colloca L; Benedetti F
Curr Opin Anaesthesiol; 2007 Oct; 20(5):435-9. PubMed ID: 17873596
[TBL] [Abstract][Full Text] [Related]
20. Rationally designed "dipeptoid" analogues of CCK. A Free-Wilson/Fujita-Ban analysis of some alpha-methyltryptophan derivatives as CCK-B antagonists.
Higginbottom M; Kneen C; Ratcliffe GS
J Med Chem; 1992 May; 35(9):1572-7. PubMed ID: 1578483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
